Effects of parathyroid hormone on Wnt signaling pathway in bone

Journal of Cellular Biochemistry

Volumn 95, Issue 6, 2005, Pages 1178-1190

  Kulkarni, N H ^a   Halladay, D L ^a   Miles, R R ^a   Gilbert, L M ^a   Frolik, C A ^a   Calvin, R J S ^a   Martin, T J ^a   Gillespie, M T ^b   Onyia, J E ^a,c  

^a ELI LILLY AND COMPANY   (United States)

^b ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c Corporate Center DC0403 ^*  (United States)

Author keywords

catenin; Bone; PTH; Rat; Wnt signaling

Indexed keywords

BETA CATENIN; CELL PROTEIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; FRIZZLED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; LUCIFERASE; LYMPHOID ENHANCER FACTOR 1; MESSENGER RNA; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PARATHYROID HORMONE; PROTEIN AXIL; PROTEIN DICKKOPF 1; PROTEIN FRIZZLED 1; PROTEIN KREMEN 1; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL CELL; ARTICLE; BONE CELL; CONTROLLED STUDY; GENE ACTIVATION; HORMONE ACTION; METAPHYSIS; NONHUMAN; OSTEOBLAST; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPORTER GENE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BONE AND BONES; CATTLE; CELL LINE, TUMOR; CYCLIC AMP; FEMALE; FORSKOLIN; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; OSTEOBLASTS; PARATHYROID HORMONE; PARATHYROID HORMONE-RELATED PROTEIN; RATS; SIGNAL TRANSDUCTION;

EID: 26444484606     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20506     Document Type: Article

References (66)

1. Akiyama T. 2000. Wnt/β-catenin signaling. Cytokine & Growth Factor Rev 11:273-282.
2. Alvarez M, Long H, Onyia J, Xu W, Bidwell J. 1997. Rat osteoblast and osteosarcoma nuclear matrix proteins bind with sequence specificity to the rat type I collagen promoter. Endocrinology 138:482-489.
3. Babich M, Choi H, Johnson RM, King KL, Alford GE, Nissenson RA. 1991. Thrombin and parathyroid hormone mobilize intracellular calcium in rat osteosarcoma cells by distinct pathways. Endocrinology 129:1463-1470.
4. Babij P, Zhao W, Small C, Kharode Y, Yaworsky PJ, Bouxsein ML, Reddy PS, Bodine PVN, Robinson JA, Bhat B, Marzolf J, Moran RA, Bex F. 2003. High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res 18:960-974.
5. Bafico A, Liu Guizhong, Yaniv A, Gazit A, Aaronson SA. 2001. Novel mechanism of Wnt signaling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nature Cell Biol 3:683-686.
6. Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP. 2002. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346:1513-1520.
7. Brott BK, Sokol SY. 2002. Regulation of WNT/LRP signaling by distinct domains of Dickkopf proteins. Mol Cell Biol 22:6100-6110.
8. Chen AE, Ginty DD, Fan CM. 2005. Protein kinase A signaling via CREB controls myogenesis induced by Wnt genes. Nature 433:208-209.
9. Civitelli R, Reid IR, Westbrook S, Avioli LV, Hruska KA. 1988. PTH elevates inositol polyphosphates and diacyglycerol in a rat osteoblast-like cell line. Am J Physiol 255:E660-E667.
10. Davidson G, Mao B, Barrantes IDB, Niehrs C. 2002. Kremen proteins interact with Dickkopf1 to regulate anteroposterior CNS patterning. Development 129:5587-5596.
11. Dempster DW, Cosman F, Parisien M, Shen V, Lindasay R. 1993. Anabolic actions of parathyroid hormone on bone. Endocr Rev 14:690-708.
12. Dobnig H, Turner RT. 1995. Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 136:3632-3638.
13. Fang X, Yu SX, Lu Y, Bast RC, Woodgett JR, Mills GB. 2000. Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Nat Acad Sci USA 97:11960-11965.
14. Frolik CA, Black EC, Cain RL, Satterwhite JH, Brown-Augsburger PL, Sato M, Hock JM. 2003. Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure. Bone 33:372-379.
15. Glinka A, Wu W, Delius H, Monaghan AP, Blumenstock C, Niehrs C. 1998. Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 391:357-362.
16. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GCM, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccolo B, Paepe AD, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Juppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinman B, Sullivan B, Superti-Furga A, Swoboda W, Boogaard MJV, Hul WV, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML. 2001. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513-523.
17. He X, Saint-Jeannet JP, Wang Y, Nathans J, Dawid I, Varmus H. 1997. A member of the Frizzled protein family mediating axis induction by Wnt-5A. Science 275:1652-1654.
18. Hock JM, Gera I. 1992. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J Bone Miner Res 7:65-72.
19. Hock JM, Fonseca GJ, Raisz LG. 1989a. Human parathyroid hormone-(1-34) increases bone mass in ovariectomized and orchidectomized rats. Endocrinology 122:2899-2904.
20. Hock JM, Fonseca J, Gunness-Hey M, Kemp BE, Martin TJ. 1989b. Comparison of the anabolic effects of synthetic parathyroid hormone-related protein (PTHrp) 1-34 and PTH 1-34 on bone in rats. Endocrinology 125:2022-2027.
21. Hsieh JC, Rattner A, Smallwood PM, Nathans J. 1999a. Biochemical characterization of Wnt-Frizzled interactions using soluble, biologically active vertebrate Wnt protein. Proc Natl Acad Sci USA 96:3546-3551.
22. Hsieh JC, Kodjabachian L, Rebbert ML, Rattner A, Smallwood PM, Samos CH, Nusse R, Dawid IB, Nathans J. 1999b. A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature 398:431-436.
23. Jerome CP, Johnson CS, Vafai HT, Kaplan KC, Bailey J, Capwell B, Fraser F, Hansen L, Ramsay H, Shadoan M, Thomsen JS, Mosekilde L. 1999. Effect of treatment for 6 months with human parathyroid hormone (1-34) peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis). Bone 25:301-309.
24. Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC. 1999. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 104:439-446.
25. Jouishomme H, Whitfield JF, Gagnon L, Maclean S, Isaacs R, Chakravarthy B, Durkin J, Neugebauer W, Willick G, Rixon RH. 1994. Further definition of the protein kinase C activation domain of the parathyroid hormone. J Bone Miner Res 9:943-949.
26. Kato M, Patel MS, Levasseur R, Lobov I, Chang BHJ, Glass DA, II, Hartmann C, Li L, Hwang TH, Brayton CF, Lang RA, Karsenty G, Chan L. 2002. Cbfa 1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in LRP5, a Wnt coreceptor. J Cell Biol 157:303-314.
27. Krupnik VE, Sharp JD, Jiang C, Robison K, Chickering TW, Amaravadi L, Brown DE, Guyot D, Mays G, Leiby K, Chang B, Duong T, Goodearl ADJ, Gearing DP, Sokol SY, McCarthy SA. 1999. Functional and structural diversity of the human Dickkopf gene family. Gene 238:301-313.
28. Li M, Wang X, Meintzer MK, Laessig T, Birnbaum MJ, Heidenreich KA. 2000. Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3β. Mol Cell Biol 20:9356-9363.
29. Little RD, Carulli JP, Del Mestro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao SC, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Eerdewegh PV, Recker RR, Johnson ML. 2002. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 70:11-19.
30. Lotinun S, Sibonga JD, Turner RT. 2002. Differential effects of intermittent and continuous administration of parathyroid hormone on bone histomorphometry and gene expression. Endocrine 17:29-36.
31. Ma YL, Cain RL, Halladay DL, Yang X, Zeng Q, Miles RR, Chandrasekhar S, Martin TJ, Onyia JE. 2001. Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology 142:4047-4054.
32. Mao J, Wang J, Liu B, Pan W, Farr GH, III, Flynn C, Yuan H, Takada S, Kimelman D, Li L, Wu D. 2001a. Low-density lipoprotein receptor-related protein-5 binds to axin and regulates the canonical Wnt signaling pathway. Mol Cell 7:801-809.
33. Mao B, Wu W, Li Y, Hoppe D, Stannek P, Glinka A, Niehrs C. 2001b. LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 411:321-325.
34. Mao B, Wu W, Davidson G, Marhold J, Li M, Mechler BM, Delhis H, Hoppe D, Stannek P, Walter C, Glinka A, Niehrs C. 2002. Kremen proteins are Dickkopf receptors that regulate Wnt/β-catenin signaling. Nature 417:664-667.
35. McClelland P, Onyia JE, Miles R, Tu Y, Liang J, Harvey AK, Chandrasekhar S, Hock J, Bidwell JP. 1998. Intermittent administration of parathyroid hormone (1-34) stimulates matrix metalloproteinase-9 (MMP-9) expression in long bone. J Cell Biochem 70:391-401.
36. Moon RT, Brown JD, Torres M. 1997. WNTs modulate cell fate and behavior during vertebrate development. Trends Genet 13:157-162.
37. Ni Z, Anini Y, Fang X, Mills G, Brubaker PL, Jin T. 2003. Transcriptional activation of the proglucagon gene by lithium and β-catenin in intestinal endocrine L cells. J Biol Chem 278:1380-1387.
38. Nykjaer A, Willnow TE. 2002. The low-density lipoprotein receptor gene family: A cellular Swiss army knife? Trends in Cell Biol 12:273-280.
39. Onyia JE, Bidwell J, Herring J, Hullman J, Hock JM. 1995. In vivo, human parathyroid hormone fragment (hPTH 1-34) transiently stimulates immediate early response gene expression, but not proliferation, in trabecular bone cells of young rats. Bone 17:479-484.
40. Onyia JE, Miller B, Hulman J, Liang J, Galvin R, Frolik C, Chandrasekhar S, Harvey AK, Bidwell J, Herring J, Hock JM. 1997. Proliferating cells in the primary spongiosa express osteoblastic phenotype in vitro. Bone 20:93-100.
41. Onyia JE, Clapp DW, Long H, Hock JM. 1998. Osteoprogenitor cells as targets for ex vivo gene transfer. J Bone Miner Res 13:20-29.
42. Onyia JE, Gelbert L, Zhang M, Bemis K, Maran A, Lin X, Chandrasekhar S, Frolik CA, Sato M, Bryant H, Turner RT. 2001. Analysis of gene expression by DNA microarray reveals novel clues to the mechanism of the catabolic and anabolic actions of PTH in bone. J Bone Miner Res 16(suppl 1):S227.
43. Oxlund H, Ejersted C, Andreassen TT, Torring O, Nilsson MHL. 1993. Parathyroid hormone (1-34) and (1-84) stimulate cortical bone formation both from periosteum and endosteum. Calcif Tissue Int 53:394-399.
44. Pinson KI, Brennan J, Monkley S, Avery BJ, Skarnes WC. 2000. An LDL-receptor-related protein mediates Wnt signaling in mice. Nature 407:535-538.
45. Potts JT, Bringhurst FR, Gardella T, Nussbaum S, Segre G, Kronenberg H. 1995. Parathyroid hormone: Physiology, chemistry, biosynthesis, secretion, metabolism and mode of action. In: DeGroot LJ, editor. Endocrinology. Philadelphia: WB Saunders. pp 920-966.
46. Radeff M, Singh ATK, Stern PH. 2004. Role of protein kinase A, phospholipase C and phospholipase D in parathyroid hormone receptor regulation of protein kinase Ca and interleukin-6 in UMR-106 osteoblastic cells. Cellular signalling 16:105-114.
47. Reeve J, Meunier PJ, Parsons JA, Bernat M, Bijvoet OL, Courpron P, Edouard C, Klenerman L, Neer RM, Renier JC, Slovik D, Vismans FJ, Potts JTJ. 1980. Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: A multicenter trial. Br Med J 280:1340-1344.
48. Riggs BL, Melton LJ, III. 1992. The prevention and treatment of osteoporosis. N Engl J Med 327:620-627.
49. Rixon RH, Whitfield JF, Gagnon L, Isaacs RJ, Maclean S, Chakravarthy B, Durkin JP, Neugebauer W, Ross V, Sung W, Willick GE. 1994. Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase. J Bone Miner Res 9:1179-1189.
50. Sato M, Zeng GQ, Turner CH. 1997. Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats. Endocrinology 138:4330-4337.
51. Scott DK, Brakenhoff KD, Clohisy JC, Quinn CO, Partridge NC. 1992. Parathyroid hormone induces transcription of collagenase in rat osteoblastic cells by a mechanism utilizing cAMP and requiring protein synthesis. Mol Endocrinol 6:2153-2159.
52. Seidensticker MJ, Behrens J. 2000. Biochemical interactions in the Wnt pathway. Biochemica et Biophysica Acta 1495:168-182.
53. Semenov MV, Tamai K, Brott BK, Kuhl M, Sokoi S, He X. 2001. Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr Biol 11:951-961.
54. Slovik DM, Neer RM, Potts JTJ. 1981. Short-term effects of synthetic human parathyroid hormone-(1-34) administration on bone mineral metabolism in osteoporotic patients. J Clin Invest 68:1261-1271.
55. Slusarski DC, Corces VG, Moon RT. 1997. Interaction of Wnt and a Frizzled homologue triggers G-protein-linked phosphatidylinositol signalling. Nature 390:410-413.
56. Tanji C, Yamamoto H, Yorioka N, Kohno N, Kikuchi K, Kikuchi A. 2002. A-kinase anchoring Protein AKAP220 binds to glycogen synthase kinase-3β (GSK-3β) and mediates protein kinase A-dependent inhibition of GSK-3β. J Biol Chem 277:36955-36961.
57. Tyson DR, Swarthout JT, Jefcoat SC, Partridge NC. 2002. PTH induction of transcriptional activity of the cAMP response element-binding protein requires the serine 129 site and glycogen synthase kinase-3 activity, but not casein kinase II sites. Endocrinology 143:674-682.
58. Uusitalo M, Heikkila M, Vainio S. 1999. Molecular genetic studies of Wnt signaling in the mouse. Exp Cell Res 253:336-348.
59. Wang YK, Samos CH, Peoples R, Perez-Jurado LA, Nusse R, Francke U. 1997. A novel human homologue of the Drosophila frizzled wnt receptor gene binds wingless protein and is in the Williams syndrome deletion at 17q11.23. Hum Mol Genet 6:465-472.
60. Wesenbeeck LV, Cleiren E, Gram J, Beals RK, Benichou O, Scopelliti D, Key L, Renton T, Bartels C, Gong Y, Warman ML, Varnejoul MCD, Bollerslev J, Hul WV. 2003. Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am J Hum Genet 72:763-771.
61. Westendorf JJ, Kahler RA, Schroeder TM. 2004. Wnt signaling in osteoblasts and bone diseases. Gene 341:19-39.
62. Wodarz A, Nusse R. 1998. Mechanism of Wnt signaling in development. Annu Rev Cell Dev Biol 14:59-89.
63. Yam JWP, Chan KW, Hsiao WLW. 2003. Transcriptional regulation of the promoter of the rat frizzled related protein gene by CREB. Oncogene 22:3901-3910.
64. Yang-Snyder J, Miller JR, Brown JD, Lai C, Moon RT. 1996. A frizzled homolog functions in a vertebrate Wnt signaling pathway. Curr Biol 6:1302-1306.
65. Zorn AM. 1997. Cell-cell signaling: Frog frizbees. Curr Biol 7:R501-R504.
66. Zorn AM. 2001. Wnt signaling: Antagonistic Dickkopfs. Curr Biol 11:R592-R595.